Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. drug research
Show results for
Products
Services
Software
Training
Applications

Companies

News
Articles
Books
Magazines
Downloads
Videos

Refine by
Date

  • This week
  • This month
  • This Year
  • Older

Drug Research Articles & Analysis

226 news found

Efficient cas 5449-12-7 and 28578-16-7 BMK PMK powder  with bulk supply

Efficient cas 5449-12-7 and 28578-16-7 BMK PMK powder with bulk supply

Pharmaceutical Intermediate Key intermediate in drug R&D and production, particularly for anti-inflammatory, analgesic, or anticancer agents. Organic Synthesis Used as a precursor for synthesizing esters, amides, and other derivatives via epoxide ring-opening reactions. Drug Development Explored for its potential in treating cancers, neurodegenerative ...

Byjiangsu yuhuo


CAS 28578-16-7 PM.K 5449-12-7 BMK Stable Output with Consistent Production

CAS 28578-16-7 PM.K 5449-12-7 BMK Stable Output with Consistent Production

Pharmaceutical Intermediate Key intermediate in drug R&D and production, particularly for anti-inflammatory, analgesic, or anticancer agents. Organic Synthesis Used as a precursor for synthesizing esters, amides, and other derivatives via epoxide ring-opening reactions. Drug Development Explored for its potential in treating cancers, neurodegenerative ...

Byjiangsu yuhuo


Factory direct supply 28578-16-7 New BMK PMK Powder 5449-12-7

Factory direct supply 28578-16-7 New BMK PMK Powder 5449-12-7

Pharmaceutical Intermediate Key intermediate in drug R&D and production, particularly for anti-inflammatory, analgesic, or anticancer agents. Organic Synthesis Used as a precursor for synthesizing esters, amides, and other derivatives via epoxide ring-opening reactions. Drug Development Explored for its potential in treating cancers, neurodegenerative ...

Byjiangsu yuhuo


CAS 5449-12-7 BM.K and cas 28578-16-7 PM.K /Supply for a long term

CAS 5449-12-7 BM.K and cas 28578-16-7 PM.K /Supply for a long term

Pharmaceutical Intermediate Key intermediate in drug R&D and production, particularly for anti-inflammatory, analgesic, or anticancer agents. Organic Synthesis Used as a precursor for synthesizing esters, amides, and other derivatives via epoxide ring-opening reactions. Drug Development Explored for its potential in treating cancers, neurodegenerative ...

Byjiangsu yuhuo


BC Platforms launches next generation trusted research environment on AWS Marketplace

BC Platforms launches next generation trusted research environment on AWS Marketplace

BC Platforms today announced enhancements to BC Mosaic, its AI-powered trusted research environment (TRE), now available on AWS Marketplace. The update delivers an all-new user interface and enables secure, compliant analysis of complex clinical, real-world, and multi-omics data within a single TRE, simplifying deployment, configuration, and lifecycle management.BC Mosaic is ...

ByBC Platforms


Advanced Tumor Organoid & CAF Co-culture Service to Accelerate Cancer Research

Advanced Tumor Organoid & CAF Co-culture Service to Accelerate Cancer Research

CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has announced the launch of its new Tumor Organoid & CAF Co-culture services to provide researchers with a more physiologically relevant in vitro tumor model, enabling a deeper understanding of tumor-stromal interactions and the development of more effective ...

ByCD Bioparticles


BOC Sciences Joins Forces with Innovators at PODD Conference 2025

BOC Sciences Joins Forces with Innovators at PODD Conference 2025

BOC Sciences is teaming up with innovators at the PODD Conference 2025 to fast-track the next generation of drug delivery. The future of medicine rests, in large part, on effective delivery systems. ...

ByBOC Sciences


CD Bioparticles Launches Purified Exosomes for Drug Delivery and Therapeutic Research

CD Bioparticles Launches Purified Exosomes for Drug Delivery and Therapeutic Research

CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has announced the availability of its quality Purified Exosomes to support research in drug delivery, regenerative medicine, and various therapeutic applications. ...

ByCD Bioparticles


CD Bioparticles Launches Advanced Bio-Targeted Small Molecules Conjugated Magnetic Nanoparticles for Targeted Cancer Therapy

CD Bioparticles Launches Advanced Bio-Targeted Small Molecules Conjugated Magnetic Nanoparticles for Targeted Cancer Therapy

Cancer cells depend heavily on glucose and glycolysis for survival and express glucose transporters. To support researchers to develop highly precise drug delivery systems, CD Bioparticles now offers various custom services for bio-targeted small molecules conjugated magnetic nanoparticles, including the synthesis of basic magnetic particles, the ...

ByCD Bioparticles


CD Formulation Offers Advanced Transdermal Delivery Enhancement Technologies

CD Formulation Offers Advanced Transdermal Delivery Enhancement Technologies

Transdermal Delivery: Overcoming Natural Barriers Traditional transdermal drug delivery has struggled with the skin’s natural barrier, the stratum corneum, which limits effective drug absorption. To address these challenges, CD Formulation utilizes an array of advanced technologies to improve drug permeability, bioavailability, and overall ...

ByCD Formulation


Creative Biostructure Expands Its Offerings for Exosomes Isolated from Stem Cell Lines

Creative Biostructure Expands Its Offerings for Exosomes Isolated from Stem Cell Lines

This strategic enhancement aims to support and accelerate research in regenerative medicine, drug delivery, and related fields by providing high-quality, stem cell-derived exosomes tailored to diverse scientific needs. ...

ByCreative Biostructure


Biopharma PEG Announces FDA DMF Registration for mPEG-pALD (20K)

Biopharma PEG Announces FDA DMF Registration for mPEG-pALD (20K)

Biopharma PEG, a leading manufacturer of high-quality polyethylene glycol (PEG) derivatives, today announced that its mPEG-pAld (20K) product has successfully achieved DMF (Drug Master File) registration with the U.S. Food and Drug Administration (FDA) under DMF number 040600. “We are thrilled to receive FDA DMF registration for our mPEG-pAld (20K) product,” said Sonia Lee, Marketing ...

ByBiopharma PEG Scientific Inc


Huateng Pharma's mPEG-pALD Receives FDA DMF Filing Approval

Huateng Pharma's mPEG-pALD Receives FDA DMF Filing Approval

(Huateng Pharma), a global leader in the development and production of high-quality PEG derivatives, is pleased to announce that its mPEG-pALD (20K) has successfully completed its Drug Master File (DMF) filing with the U.S. Food and Drug Administration (FDA), under DMF No. 040600. ...

ByHunan Huateng Pharmaceutical Co. Ltd.


CD Bioparticles Announces Enhanced Online Ordering System for Improved Customer Experience

CD Bioparticles Announces Enhanced Online Ordering System for Improved Customer Experience

However, industry and research laboratories face challenges in analyzing complex and diverse samples and require sensitive and reliable drug delivery systems to provide consistent results in support of analytical studies and assays. ...

ByCD Bioparticles


Diving Deeper in Rare Disease Research: Protheragen Unveils Diagnostic Development Services

Diving Deeper in Rare Disease Research: Protheragen Unveils Diagnostic Development Services

Protheragen, a dedicated preclinical research service provider specializing in rare diseases, announces its comprehensive diagnostic development services aimed at empowering researchers in the realm of rare disease research and drug development. ...

ByProtheragen


CD Formulation Reveals Specialty in Oral Thin Film Manufacturing Technologies

CD Formulation Reveals Specialty in Oral Thin Film Manufacturing Technologies

CD Formulation’s commitment to innovation is evident in their comprehensive suite of services, meticulously designed to meet the unique needs of researchers focusing on drug development and delivery. One of the cornerstones of CD Formulation’s technological prowess lies in solvent casting. ...

ByCD Formulation


Ace Therapeutics Launches Gene Therapy Development Services to Unleash Glaucoma Drug Research

Ace Therapeutics Launches Gene Therapy Development Services to Unleash Glaucoma Drug Research

This new initiative is set to advance research in glaucoma treatments, offering comprehensive support and innovation for researchers and pharmaceutical companies aiming to cure this pervasive eye disease. ...

ByAce Therapeutics


Protheragen-ING AI-Pharma’s AI-Powered Drug Discovery and Design Platform—A Paradigm Shift in Drug Development

Protheragen-ING AI-Pharma’s AI-Powered Drug Discovery and Design Platform—A Paradigm Shift in Drug Development

In the ever-evolving landscape of pharmaceutical research and development, the demand for innovative and efficient drug discovery methods is more pressing than ever. At the forefront of this demanding field is Protheragen-ING AI-Pharma, a contract research and development biotechnology company, offering cutting-edge solutions to ...

ByProtheragen-ING


CD Formulation Is A Reliable Provider of Customized Drug Conjugates Services

CD Formulation Is A Reliable Provider of Customized Drug Conjugates Services

Specializing in complex biologic formulations, Biologics & Biosimilars service team of CD Formulation is revolutionizing how drug conjugate products are conceptualized and produced, standing out as a crucial ally in drug research and development. ...

ByCD Formulation


BOC Sciences Opens Registration for the Webinar on Peptide-Drug Conjugates (PDCs)

BOC Sciences Opens Registration for the Webinar on Peptide-Drug Conjugates (PDCs)

Kelly Bugatti, BOC Sciences is set to host an informative webinar that will delve into the latest advancements in utilizing Peptide-Drug Conjugates (PDCs) for the targeted treatment of Pulmonary Fibrosi BOC Sciences has been organizing regular webinars in the fields of life sciences, drug discovery, and chemistry. This year, BOC Sciences is honored to welcome ...

ByBOC Sciences

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT